JP2024514477A5 - - Google Patents
Info
- Publication number
- JP2024514477A5 JP2024514477A5 JP2023560004A JP2023560004A JP2024514477A5 JP 2024514477 A5 JP2024514477 A5 JP 2024514477A5 JP 2023560004 A JP2023560004 A JP 2023560004A JP 2023560004 A JP2023560004 A JP 2023560004A JP 2024514477 A5 JP2024514477 A5 JP 2024514477A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- tcr
- amino acid
- acid sequence
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163167433P | 2021-03-29 | 2021-03-29 | |
| US63/167,433 | 2021-03-29 | ||
| US202163210198P | 2021-06-14 | 2021-06-14 | |
| US63/210,198 | 2021-06-14 | ||
| US202263314870P | 2022-02-28 | 2022-02-28 | |
| US63/314,870 | 2022-02-28 | ||
| PCT/US2022/022324 WO2022212361A1 (en) | 2021-03-29 | 2022-03-29 | Peptides and engineered t cell receptors targeting sars-cov-2 antigens and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024514477A JP2024514477A (ja) | 2024-04-02 |
| JP2024514477A5 true JP2024514477A5 (cg-RX-API-DMAC7.html) | 2025-04-07 |
Family
ID=83456819
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560004A Pending JP2024514477A (ja) | 2021-03-29 | 2022-03-29 | Ｓａｒｓ－ｃｏｖ－２抗原を標的とするペプチドおよび操作されたｔ細胞受容体ならびに使用の方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240293459A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4313139A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024514477A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240005714A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022246811A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022212361A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4716699A2 (en) * | 2023-05-22 | 2026-04-01 | Board of Regents, The University of Texas System | Peptides and engineered t cell receptors targeting brachyury antigen and methods of use |
| CN117659140B (zh) * | 2023-10-26 | 2026-05-05 | 中国人民解放军海军军医大学 | 新冠病毒hla-a2限制性表位肽及应用 |
| KR20250115147A (ko) | 2024-01-23 | 2025-07-30 | 국립경국대학교 산학협력단 | 재조합 ＳＡＲＳＣｏＶ２ 렌티바이러스 벡터를 이용한 ＳＡＲＳＣｏＶ２ 자가면역 백신의 제조방법 |
| WO2026019786A1 (en) * | 2024-07-16 | 2026-01-22 | Board Of Regents, The University Of Texas System | Peptides and engineered t cell receptors targeting brachyury antigen and methods of use |
| TW202615096A (zh) * | 2024-07-19 | 2026-04-16 | 國立大學法人京都大學 | SARS-CoV-2感染症治療及/或預防用細胞及其製法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004110349A2 (en) * | 2003-05-14 | 2004-12-23 | Siga Technologies, Inc. | Sars t cell epitopes and methods for identifying same |
| MX2020001879A (es) * | 2017-08-18 | 2020-07-29 | Gritstone Oncology Inc | Proteínas de fijación al antígeno que se dirigen a antígenos compartidos. |
| AU2018395397A1 (en) * | 2017-12-28 | 2020-08-06 | Gritstone Bio, Inc. | Antigen-binding proteins targeting shared antigens |
| WO2024227034A1 (en) * | 2023-04-27 | 2024-10-31 | Serum Detect, Inc. | T-cell receptor signatures indicative of early stages of cancer |
-
2022
- 2022-03-29 KR KR1020237037284A patent/KR20240005714A/ko active Pending
- 2022-03-29 JP JP2023560004A patent/JP2024514477A/ja active Pending
- 2022-03-29 US US18/552,417 patent/US20240293459A1/en active Pending
- 2022-03-29 EP EP22782016.4A patent/EP4313139A4/en active Pending
- 2022-03-29 WO PCT/US2022/022324 patent/WO2022212361A1/en not_active Ceased
- 2022-03-29 AU AU2022246811A patent/AU2022246811A1/en active Pending